Willdan Group, Inc. (WLDN)

Regulus Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jul 31, 2025	Dec 27, 2024	Dec 29, 2023	Dec 30, 2022	Dec 31, 2021	Jan 1, 2021
Market Capitalization	1,237	543	293	237	450	503
Market Cap Growth	39.67%	84.91%	23.64%	-47.30%	-10.57%	42.55%
Enterprise Value	1,289	601	397	354	566	632
Last Close Price	82.62	38.41	21.50	17.85	35.20	41.70
PE Ratio	50.82	24.04	26.85	-	-	-
Forward PE	40.90	25.61	31.97	-	-	-
PS Ratio	1.94	0.96	0.57	0.55	1.27	1.29
PB Ratio	4.88	2.32	1.47	1.31	2.51	2.98
P/TBV Ratio	41.91	8.49	7.99	23.99	-	-
P/FCF Ratio	30.81	8.52	10.02	-	345.30	12.00
P/OCF Ratio	25.25	7.53	7.48	25.16	45.93	10.71
EV/Sales Ratio	2.16	1.06	0.78	0.83	1.60	1.62
EV/EBITDA Ratio	26.34	13.03	10.31	33.97	66.95	251.08
EV/EBIT Ratio	38.67	19.16	17.98	-	-	-
EV/FCF Ratio	32.48	9.44	13.55	-	434.12	15.06
Debt / Equity Ratio	0.43	0.46	0.57	0.68	0.66	0.80
Debt / EBITDA Ratio	1.77	1.93	2.39	6.26	6.44	10.45
Debt / FCF Ratio	2.63	1.70	3.93	-	90.67	3.24
Asset Turnover	1.36	1.29	1.24	1.07	0.89	0.93
Quick Ratio	1.55	1.68	1.64	1.23	1.23	1.29
Current Ratio	1.61	1.71	1.67	1.37	1.27	1.34
Return on Equity (ROE)	10.78%	10.40%	5.73%	-4.68%	-4.83%	-8.62%
Return on Assets (ROA)	4.74%	4.45%	3.34%	-1.10%	-1.36%	-2.41%
Return on Capital (ROIC)	6.24%	5.96%	4.45%	-1.47%	-1.80%	-3.23%
Return on Capital Employed (ROCE)	9.60%	9.60%	7.30%	-	-	-
Earnings Yield	1.99%	4.16%	3.72%	-3.56%	-1.87%	-2.88%
FCF Yield	3.25%	11.73%	9.98%	-0.07%	0.29%	8.33%
Buyback Yield / Dilution	-5.17%	-4.70%	-4.56%	-4.46%	-5.64%	-0.23%

Updated May 8, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q